Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3 009 258 men

Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3 009 258 men

Bibliographic Details
Main Author:	Leonardo Oliveira Reis
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia 2011-08-01
Series:	International Brazilian Journal of Urology
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000400030

Similar Items

Nationwide incidence and treatment pattern of benign prostatic hyperplasia in Korea
by: Young Ju Lee, et al.
Published: (2016-11-01)

Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study
by: Yu‐Jui Kuo, et al.
Published: (2019-05-01)

THE FACTORS ASSOCIATED WITH THE INCIDENCE OF BENIGN PROSTATIC HYPERPLASIA
by: sukron sukron
Published: (2022-07-01)

Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
by: Moussa Laanani, et al.
Published: (2023-03-01)

Benign Prostatic Hyperplasia
Published: (2015-01-01)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
by: Ida Bagus O.W. Putra, et al.
Published: (2016-06-01)

Correlation of prostate volume with 'International Prostate Symptom Score' and 'Benign Prostatic Hyperplasia-Impact Index' in benign prostatic hyperplasia
by: D Gnyawali, et al.
Published: (2016-07-01)

Tuberculosis of the prostate presenting as benign prostatic hyperplasia.
by: Fazarina M,, et al.
Published: (2013)

Benign prostatic hyperplasia and prostate-specific antigen
by: Pejčić Tomislav, et al.
Published: (2015-01-01)

Immunohistochemical analysis of estrogen receptors in prostate and clinical correlation in men with benign prostatic hyperplasia
by: Goto Gangkak, et al.
Published: (2017-03-01)

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia
by: Ebenezer Abotsi, et al.
Published: (2022-12-01)

Testosterone and benign prostatic hyperplasia
by: Thomas R Jarvis, et al.
Published: (2015-04-01)

Nocturia and benign prostatic hyperplasia
by: Laketić Darko, et al.
Published: (2008-01-01)

Huge Benign Prostatic Hyperplasia
by: Seyed Yousef Hosseini, et al.
Published: (2004-06-01)

Mortality trends for benign prostatic hyperplasia and prostate cancer in English populations 1979-2006.
by: Duncan, M, et al.
Published: (2011)

Association between benign prostatic hyperplasia and suicide in South Korea: A nationwide retrospective cohort study.
by: Sang-Uk Lee, et al.
Published: (2022-01-01)

Prostatitis and Benign Prostatic Hyperplasia: Emerging Infectious Diseases?
by: Brad Hennenfent
Published: (1997-03-01)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
by: Somsri Wiwanitkit, et al.
Published: (2012-01-01)

Improvement of sexual function in men with benign prostatic hyperplasia by pharmacologic therapy
by: Stojanović Nebojša, et al.
Published: (2014-01-01)

The effectiveness of reducing the daily dose of finasteride in men with benign prostatic hyperplasia
by: Geller Jack, et al.
Published: (2002-01-01)

Metabolic Syndrome and Benign Prostatic Hyperplasia/What Component of Metabolic Syndrome Is Related to Benign Prostatic Hyperplasia?
by: Bahar Arıcan Tarım, et al.
Published: (2023-09-01)

EMBOLIZATION AND CHEMOEMBOLIZATION PROSTATIC ARTERIES OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
by: N. B. Tabynbaev, et al.
Published: (2017-05-01)

Drug treatment for benign prostatic hyperplasia.
by: Farmer, A, et al.
Published: (1997)

Drug treatment for benign prostatic hyperplasia
by: Farmer, A, et al.
Published: (1997)

Doxazocin in management of benign prostatic hyperplasia
by: N K Mohanty, et al.
Published: (2003-01-01)

Silodosin in the treatment of benign prostatic hyperplasia
by: Maxime Rossi, et al.
Published: (2010-10-01)

Epidemiology of clinical benign prostatic hyperplasia
by: Kok Bin Lim
Published: (2017-07-01)

Is Effective in the Treatment of Benign Prostatic Hyperplasia?
by: Gökhan Çeker MD
Published: (2020-06-01)

Solving the benign prostatic hyperplasia puzzle
by: Keong Tatt Foo
Published: (2016-01-01)

Pathophysiology of clinical benign prostatic hyperplasia
by: Keong Tatt Foo
Published: (2017-07-01)

Optimizing the management of benign prostatic hyperplasia
by: Dean S. Elterman, et al.
Published: (2012-04-01)

Botulinum toxin and benign prostatic hyperplasia
by: Lay Guat Ng
Published: (2018-01-01)

The preventive effect of metformin on progression of benign prostate hyperplasia: A nationwide population-based cohort study in Korea.
by: Yehee Hong, et al.
Published: (2019-01-01)

Lifestyle habits to prevent the development of benign prostatic hyperplasia: Analysis of Japanese nationwide datasets
by: Yukinori Nagakura, et al.
Published: (2022-12-01)

INTERVENTIONAL SURGERY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
by: A. I. Neymark, et al.
Published: (2015-09-01)

Adipocytokine levels in benign prostate hyperplasia and prostate cancer patients
by: Gokhan Temeltas, et al.
Published: (2017-09-01)

Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
by: Weronika Ratajczak, et al.
Published: (2022-01-01)

Herbal therapy for patients with benign prostatic hyperplasia and chronic prostatitis
by: GG Krivoborodov, et al.
Published: (2014-12-01)

Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer
by: Alexander Glaser, et al.
Published: (2022-09-01)

Prostate Artery Embolization: Treatment of Symptomatic Benign Prostatic Hyperplasia
by: Jin Ho Hwang, et al.
Published: (2019-07-01)